Form D · Biotechnology

Aeglea BioTherapeutics Holdings, LLC

Austin, TX · CIK 0001595365

Offering snapshot reported Jul 28, 2014 · SEC filing

Reported sold
$10.7M
Offering amount: $11M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 24, 2013
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$5.35M$10.7MJan 8, 2014: $5,102,632.00Jan 8, 2014Jul 28, 2014: $10,707,500.00Jul 28, 2014

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$5,102,632 → $10,707,500
  • Reported investors4 → 10

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 28, 2014Amendment$10,707,500$5,604,868vs Jan 8, 201410SEC filing
Jan 8, 2014Initial$5,102,632No comparison4SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-209533

Source: Form D, filed Jul 28, 2014. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
George Georgiou Director
David Lowe Director, Executive
Armen Shanafelt Director
Henry Skinner Director
Charles York Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
815 A Brazos Street #101
Austin, TX, 78701